Skip to main content
JA Clinical Reports
Fig. 1 | JA Clinical Reports

Fig. 1

From: Anesthetic management for withdrawal from a right ventricular assist device and Fontan procedure in a patient with an implantable left ventricular assist device for fulminant cardiomyopathy

Fig. 1

Clinical progression until surgery. The patient had no medical history. He developed malaise on day 0 and fever on day 1. On day 4, the patient was diagnosed with fulminant cardiomyopathy by the previous physician and administered catecholamines. On day 5, he was treated with VA-ECMO and an Impella CP left ventricular assist device (Abiomed Inc., Danvers, MA, USA). On day 6, the patient was transferred to our hospital for more advanced treatment. ECMO, extracorporeal membrane oxygenation; VA-ECMO, blood is extracted from the right atrium and returned to the arterial system, bypassing the heart and lungs; Central ECMO, blood is extracted from the right atrium and left ventricle and returned to the pulmonary artery and aortic artery, bypassing the heart and lungs; BiVAD, biventricular assist device; HM3, HeartMate 3 implantable left ventricular assist device (Abbott); RVAD, right ventricular assist device; AVP, aortic valve plasty; EC-TCPC, extracardiac conduit–total cavopulmonary connection

Back to article page